Disease process and drug treatments in Parkinson's disease.
Leenders
K L
KL
Groningen University Hospital (AZG), Hanzeplein 1, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands. k.l.leenders@neuro.azg.nl
D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology / Q000627:therapeutic use; D001479:Basal Ganglia / Q000000981:diagnostic imaging / Q000378:metabolism; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000473:pathology; D018450:Disease Progression; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use; D010300:Parkinson Disease / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D014055:Tomography, Emission-Computed
D000978:Antiparkinson Agents; D018696:Neuroprotective Agents; D019275:Radiopharmaceuticals; D004298:Dopamine